Home » Topics » Regulatory » EMA

EMA
RSS

GSK withdraws indication extension application for Tyverb

Feb. 17, 2012

CPP-115 receives European orphan drug status

Feb. 14, 2012

Alexza Pharmaceuticals receives first feedback on Adasuve MAA

Feb. 14, 2012

Navidea Biopharmaceuticals receives CHMP advice on Lymphoseek MAA

Feb. 2, 2012

Indication for Gadovist 1.0 is expanded

Jan. 30, 2012

Novartis reflects on accomplishments of 2011

Jan. 30, 2012

CHMP issues opinion on Remicade for ulcerative colitis in children

Jan. 26, 2012

CHMP recommends updating Glivec label in Europe

Jan. 24, 2012

EMA recommends marketing suspension for meprobamate-containing medicines

Jan. 23, 2012

EMA reviews Gilenya following reports of heart problems in patients

Jan. 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...